Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kshazand
    Junior Member
    • May 2008
    • 8

    #1

    Nextera DNA Flex performance

    Hi,
    I wonder if someone can share some library QC information (Picard type) on the new Nextera DNA Flex, such as dupe rate, estimated library size, GC bias, etc. This needs to be without enrichment, of course.
    Thanks,
    Kamran
    Kamran SHAZAND, PhD
  • thermophile
    Senior Member
    • Apr 2015
    • 243

    #2
    I tested the new kit on my extreme problem bacterial genomes (>70% GC). It appears that the cut site bias is basically the same for the flex as it has been for the other flavors of nextera. the library prep is nice an easy, I'll likely move to flex for standard genomes but difficult ones continue to need manual shearing
    Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

    Comment

    • kshazand
      Junior Member
      • May 2008
      • 8

      #3
      Thanks for the reply. If there is still a bias, there should be a heterogeneous coverage. Are you comfortable with that?
      Kamran SHAZAND, PhD

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Yesterday, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      71 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...